SC
AONCW

Sculptor Capital’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Sculptor Capital’s Portfolio AONCW Stock Details AONCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-128,972
Closed -$41.9K – 380
2024
Q1 		$41.9K Hold
128,972
– – ﹤0.01% 246
2023
Q4 		$28.4K Hold
128,972
– – ﹤0.01% 275
2023
Q3 		$23.9K Hold
128,972
– – ﹤0.01% 311
2023
Q2 		$20.1K Sell
128,972
-2,903
-2% -$238 ﹤0.01% 336
2023
Q1 		$9.44K Hold
131,875
– – ﹤0.01% 476
2022
Q4 		$8.86K Hold
131,875
– – ﹤0.01% 689
2022
Q3 		$9K Hold
131,875
– – ﹤0.01% 979
2022
Q2 		$11K Hold
131,875
– – ﹤0.01% 1088
2022
Q1 		$45K Hold
131,875
– – ﹤0.01% 1089
2021
Q4 		$80K Hold
131,875
– – ﹤0.01% 1017
2021
Q3 		$91K Hold
131,875
– – ﹤0.01% 853
2021
Q2 		$125K Buy
+131,875
New +$105K ﹤0.01% 828

Other funds holding AONCW

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Sculptor Capital's AONCW Position: Q2 2024 in Review

Sculptor Capital sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2024, closing a stake of 128,972 shares — an estimated $41.9K sold.

Sculptor Capital first reported a position in AONCW in Q2 2021 and held it in 12 quarters. The position peaked at $125K in Q2 2021. 3 funds tracked by Wall St. Rank hold AONCW as of Q2 2024.

  • Sculptor Capital reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
  • Sculptor Capital sold 128,972 American Oncology Network, Inc. Warrant shares in Q2 2024, an estimated $41.9K.
  • Sculptor Capital first reported a position in American Oncology Network, Inc. Warrant in Q2 2021 and held it in 12 quarters.
  • Sculptor Capital's American Oncology Network, Inc. Warrant position peaked at $125K in Q2 2021.
  • 3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2024.

Based on Sculptor Capital's 13F filing for Q2 2024, filed 14 Aug 2024.